Results for
"[search-keyword]"
Sponsor content
811 result(s) found, displaying 171 to 180
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CIPTUNEC adalimumab 40 mg/0.4 mL solution for subcutaneous injection pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ADALICIP adalimumab 40 mg/0.4 mL solution for subcutaneous injection pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CIPTUNEC adalimumab 80 mg/0.8 mL solution for subcutaneous injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ADALICIP adalimumab 80 mg/0.8 mL solution for subcutaneous injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ADALICIP adalimumab 40 mg/0.4 mL solution for subcutaneous injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CIPTUNEC adalimumab 40 mg/0.4 mL solution for subcutaneous injection pre-filled syringe.
-
Australian Public Assessment Report (AusPAR)AusPAR for Filpegla (pegfilgrastim) for the treatment of cancer patients following chemotherapy, to decrease the duration of severe neutropenia.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FILPEGLA pegfilgrastim 6 mg/0.6 mL solution for injection syringe.
-
Australian Public Assessment Report (AusPAR)Ardalicip / Ciptunec (adalimumab) for the treatment of arthritis, crohn's disease, ulcerative colitis, psoriasis, uveitis and acne inversa.
-
Prescription medicine registrationActive ingredients: Methotrexate.